Launch sequence optimization

Determine tactical market launch strategies for new a pharmaceutical product based on market opportunity.

Power your strategic decision-making

with data-driven insights and collaborative consulting

Leverage our experience and expertise to establish a market launch sequence strategy by balancing clinical priorities, market opportunity, and price potential.

Cogni, your collaborative consulting platform, goes beyond the data with expert analysis and real-time recommendations tailored to your strategic imperatives.

Clinical landscaping

  • Inform launch sequence prioritization through analysis of burden of disease and unmet need within target markets.
  • Evaluate the size of the addressable population for your product across target markets to determine market potential.

Competitive landscaping

  • Establish launch attractiveness and market opportunity though current and future competitive landscaping.

Market value and price benchmarking

  • Review price corridors within target markets to inform early pricing assumptions and guide launch sequencing.

  • Select optimal launch windows to avoid direct competition, maximizing market penetration and revenue.
  • Prioritize launch in countries or regions with high market potential and minimal competitive barriers, ensuring rapid market entry and uptake and efficient resourcing.
  • Launch first in markets with favorable regulatory pathways, accelerating time to market and reducing risks.
  • Align your pricing strategies to each market’s economic environment and payer expectations, optimizing market access and uptake.
  • Tailor your product value propositions and Health Economics and Outcomes Research (HEOR) strategies to highlight region-specific economic and clinical benefits and enhance payer acceptance.

Contact us

All delivered as strategic reports, interactive intelligence dashboards and scenario planning tools, placing an optimal strategy at your fingertips.

Delivered through Cogni

Cogni by VISFO logo

Collaborative
consulting platform

  • High-impact strategic guidance built on a legacy of successful drug development and product launches

  • Bespoke knowledge management and collaboration software

  • Instant access to evolving outputs for quick report generation and sharing

A VISFO "intelligence board" showing elements of the "Addressable patient population" mapping service offering displayed on both a desktop and mobile screen. Included are "Interpretation" and "Activity" sections, with fields for adding comments and viewing activity logs.